Changes in BiP expression induced by mutant variants of APP are consistent with the activation of UPR signaling in the early stages of experimental AD modeling [212,213,242,246] and the possibility of UPR depletion during the later stages [245,247]. The gene discussed is HSPA5; the disease is Alzheimer disease.